アトラキネニンAとBの総合成
Sarah A French1, Christopher J Sumby1, David M Huang1
1Department of Chemistry, The University of Adelaide, Adelaide, SA 5005, Australia.
Journal of the American Chemical Society
|December 12, 2022
まとめ
この研究は,アトラヒネンインAとBのバイオミメティック・トータル・シンセシスを提示し,新しい生物合成仮説を通してそのレースミックな性質を説明している. 主要な反応はダイエルス・アルダーとサイクロアディションで,複雑な多循環構造が得られる.
科学分野:
- 有機化学
- 自然製品合成
- 生物合成
背景:
- アトラキネニンAとBは複合的な多循環構造を持つ天然産物である.
- 生物合成経路と血性性質の理由は以前は不明でした
研究 の 目的:
- アトラキネニンAとBのバイオミメティック・トータル・シンセシスを達成する.
- 生物合成の起源を明らかにし,これらの化合物の観察されたラセミック性質を説明する.
主な方法:
- 合成は,キノンのメロテルペノイドとE-β-オシメンの間の分子間ダイエルス-アルダー反応を用いた.
- 分子内 (3 + 2) サイクル添加と後期のアエロビック酸化が決定的なステップでした.
- 異なる変換を探求するためにモデルシステムが使用されました.
主要な成果:
- アトラキネニンAとBのバイオミメティック完全合成が成功しました.
- 合成経路は,化合物のラセミック性についてのメカニズム的説明を提供した.
- 複合的な多循環構造が生成され,アトラヒネニンCの構造修正が提案された.
結論:
- 提案された生合成仮説と生体模倣合成は,アトラヒネニン形成の洞察を提供します.
- この研究は,これらの天然製品の構造的側面と合成のアクセシビリティを明確にします.
- この研究は,関連する天然製品とその生物合成のさらなる探求のための基盤を提供します.
関連する概念動画
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
2.3K
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
2.3K
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.2K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.2K
Direct-Acting Cholinergic Agonists: Pharmacokinetics
1.3K
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
1.3K
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
1.1K
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
1.1K
Adrenergic Receptors: ɑ Subtype
1.7K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
1.7K
Adrenergic Receptors: β Subtype
1.8K
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
1.8K


